| Primary |
| Drug Use For Unknown Indication |
28.0% |
| Convulsion |
24.0% |
| Grand Mal Convulsion |
15.0% |
| Product Used For Unknown Indication |
8.0% |
| Tremor |
7.0% |
| Epilepsy |
6.0% |
| Essential Tremor |
4.0% |
| Complex Partial Seizures |
2.0% |
| Parkinson's Disease |
2.0% |
| Back Pain |
1.0% |
| Coronary Artery Bypass |
1.0% |
| Muscle Spasms |
1.0% |
| Rett's Disorder |
1.0% |
|
| Therapeutic Response Unexpected With Drug Substitution |
17.4% |
| Pharmaceutical Product Complaint |
13.0% |
| Nausea |
6.5% |
| Product Substitution Issue |
6.5% |
| Stubbornness |
6.5% |
| Tremor |
6.5% |
| Weight Decreased |
6.5% |
| Death |
4.3% |
| Homicide |
4.3% |
| Schizophrenia |
4.3% |
| Skin Laceration |
4.3% |
| Completed Suicide |
2.2% |
| Convulsion |
2.2% |
| Feeling Abnormal |
2.2% |
| Hypoaesthesia |
2.2% |
| Ill-defined Disorder |
2.2% |
| Lymphoma |
2.2% |
| Maternal Drugs Affecting Foetus |
2.2% |
| Migraine |
2.2% |
| No Adverse Reaction |
2.2% |
|
| Secondary |
| Grand Mal Convulsion |
20.3% |
| Epilepsy |
13.6% |
| Product Used For Unknown Indication |
10.3% |
| Convulsion |
9.7% |
| Drug Use For Unknown Indication |
8.2% |
| Back Pain |
6.9% |
| Hypertension |
5.1% |
| Essential Tremor |
4.4% |
| Depression |
2.6% |
| Essential Hypertension |
2.6% |
| Ill-defined Disorder |
2.6% |
| Atrial Fibrillation |
2.3% |
| Convulsion Prophylaxis |
2.1% |
| Diabetes Mellitus |
2.1% |
| Dyslipidaemia |
2.1% |
| Extrapyramidal Disorder |
1.5% |
| Parkinson's Disease |
1.0% |
| Prophylaxis Of Nausea And Vomiting |
1.0% |
| Tremor |
1.0% |
| Pain |
0.8% |
|
| Weight Decreased |
33.0% |
| Wheezing |
10.2% |
| Toxicity To Various Agents |
6.8% |
| Persecutory Delusion |
5.7% |
| Cytolytic Hepatitis |
4.5% |
| Drug Interaction |
4.5% |
| Posterior Reversible Encephalopathy Syndrome |
3.4% |
| Stubbornness |
3.4% |
| Transaminases Increased |
3.4% |
| Drug Hypersensitivity |
2.3% |
| Hypertension |
2.3% |
| Hyponatraemia |
2.3% |
| Migraine |
2.3% |
| Poor Quality Drug Administered |
2.3% |
| Skin Hyperpigmentation |
2.3% |
| Spinal Fracture |
2.3% |
| Tremor |
2.3% |
| Unresponsive To Stimuli |
2.3% |
| Vision Blurred |
2.3% |
| Vitamin B12 Increased |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
12.6% |
| Hypertension |
11.0% |
| Convulsion |
8.0% |
| Epilepsy |
7.7% |
| Drug Use For Unknown Indication |
7.3% |
| Osteoporosis |
6.9% |
| Tremor |
5.7% |
| Pain |
5.1% |
| Parkinson's Disease |
4.5% |
| Depression |
4.0% |
| Bipolar Disorder |
3.8% |
| Ischaemic Cardiomyopathy |
3.1% |
| Myocardial Ischaemia |
3.1% |
| Anxiety |
2.7% |
| Asthma |
2.7% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
| Multiple Myeloma |
2.5% |
| Multiple Sclerosis |
2.5% |
| Gastrooesophageal Reflux Disease |
2.3% |
| Rheumatoid Arthritis |
1.9% |
|
| Weight Decreased |
18.5% |
| Convulsion |
6.2% |
| Vomiting |
6.2% |
| Renal Failure |
5.5% |
| Upper Respiratory Tract Infection |
5.5% |
| Pneumonia |
4.8% |
| Weight Increased |
4.8% |
| Gastrooesophageal Reflux Disease |
4.1% |
| Malaise |
4.1% |
| Myocardial Infarction |
4.1% |
| Nausea |
4.1% |
| Pathological Gambling |
4.1% |
| Product Substitution Issue |
4.1% |
| Multiple Sclerosis |
3.4% |
| Pain In Extremity |
3.4% |
| Sedation |
3.4% |
| Tremor |
3.4% |
| Upper Limb Fracture |
3.4% |
| Urinary Tract Infection |
3.4% |
| X-ray Abnormal |
3.4% |
|
| Interacting |
| Lennox-gastaut Syndrome |
71.4% |
| Bipolar Disorder |
14.3% |
| Sleep Disorder |
7.1% |
| Tremor |
7.1% |
|
| Status Epilepticus |
50.0% |
| Blood Pressure Increased |
25.0% |
| Drug Interaction |
25.0% |
|
